359766-18-0

Upstream product

• 40217-17-2 (R)-4-(phenylmethyl)-2-oxazolidinone 
• 359766-23-7 (4E,6E)-(S)-4,8-Dimethyl-deca-4,6-dienoic acid 
• 359766-21-5 2-((2E,4E)-(S)-2,6-Dimethyl-octa-2,4-dienyl)-malonic acid diethyl ester 
• 359766-22-6 2-((2E,4E)-(S)-2,6-Dimethyl-octa-2,4-dienyl)-malonic acid 
• 359766-20-4 Acetic acid (2E,4E)-(S)-2,6-dimethyl-octa-2,4-dienyl ester 
• 359766-19-1 (2E,4E)-(S)-2,6-Dimethyl-octa-2,4-dienoic acid ethyl ester 
• 359766-35-1 (2E,4E)-(S)-2,6-Dimethyl-octa-2,4-dien-1-ol 

Downstream Products

• 359766-24-8 (R)-4-Benzyl-3-((4E,6E)-(2R,8S)-2,4,8-trimethyl-deca-4,6-dienoyl)-oxazolidin-2-one 

Relevant academic research and scientific papers

Total synthesis of nafuredin, a selective NADH-fumarate reductase inhibitor.

[structure: see text] Total synthesis of nafuredin, a selective NADH-fumarate reductase inhibitor, has been accomplished by a convergent approach. The C1-C8 and C9-C18 segments were derived efficiently from D-glucose and (S)-(-)-2-methyl-1-butanol, respectively, coupled by stereoselective Julia olefination, and converted to nafuredin.